Conmed (CNMD) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.62% |
| Dec 31, 2025 | 18.13% |
| Sep 30, 2025 | 8.85% |
| Jun 30, 2025 | 39.38% |
| Mar 31, 2025 | 62.01% |
| Dec 31, 2024 | 1.18% |
| Sep 30, 2024 | 6.95% |
| Jun 30, 2024 | 14.95% |
| Mar 31, 2024 | 56.64% |
| Dec 31, 2023 | 17.95% |
| Sep 30, 2023 | 60.35% |
| Jun 30, 2023 | 5.28% |
| Mar 31, 2023 | -16.58% |
| Dec 31, 2022 | -20.66% |
| Sep 30, 2022 | 14.03% |
| Jun 30, 2022 | 3.18% |
| Mar 31, 2022 | -53.63% |
| Dec 31, 2021 | 19.80% |
| Sep 30, 2021 | -2.91% |
| Jun 30, 2021 | 13.77% |
| Mar 31, 2021 | 27.35% |
| Dec 31, 2020 | 10.56% |
| Sep 30, 2020 | 20.78% |
| Jun 30, 2020 | -11.57% |
| Mar 31, 2020 | -24.14% |
| Dec 31, 2019 | 9.77% |
| Sep 30, 2019 | 20.15% |
| Jun 30, 2019 | 22.29% |
| Mar 31, 2019 | -17.40% |
| Dec 31, 2018 | -1.99% |
| Sep 30, 2018 | -32.25% |
| Jun 30, 2018 | 3.13% |
| Mar 31, 2018 | 35.53% |
| Dec 31, 2017 | -9.32% |
| Sep 30, 2017 | -13.66% |
| Jun 30, 2017 | -8.97% |
| Mar 31, 2017 | 14.93% |
| Dec 31, 2016 | -12.23% |
| Sep 30, 2016 | -7.46% |
| Jun 30, 2016 | -1.63% |
| Mar 31, 2016 | -22.87% |
| Dec 31, 2015 | -11.88% |
| Sep 30, 2015 | 6.95% |